NeuroSigma Announces Strategic Digital Marketing Partnership with Data360
31 janv. 2023 09h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, Jan. 31, 2023 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company commercializing external trigeminal nerve stimulation (eTNS) technology for treating...
WishBone Medical Partners With Clubfoot Solutions to Distribute the Iowa Brace for Pediatric Patients in the U.S.
05 janv. 2023 08h00 HE
|
WishBone Medical, Inc.
WARSAW, Ind., Jan. 05, 2023 (GLOBE NEWSWIRE) -- WishBone Medical, Inc. has entered into a distribution agreement with Clubfoot Solutions, naming WishBone the exclusive pediatric medical device...
San Antonio TX Dentist Dr. Carlen Blume of Blume Pediatric Dentistry Interviewed by Qamar Zaman
19 déc. 2022 21h28 HE
|
The Subject Matter Expert Podcast by Qamar Zaman
San Antonio, TX, Dec. 19, 2022 (GLOBE NEWSWIRE) -- In 2010, Dr. Carlen Blume established her pediatric dentistry practice and has become one of the go-to full-service pediatric care providers...
Extracorporeal Membrane Oxygenation Market to hit USD 639 Million by 2032, says Global Market Insights Inc.
12 déc. 2022 06h10 HE
|
Global Market Insights Inc.
Selbyville, Delaware, Dec. 12, 2022 (GLOBE NEWSWIRE) -- The extracorporeal membrane oxygenation market value is set to reach USD 639 million by 2032, according to a new research report by Global...
爱科百发宣布呼吸道合胞病毒新药爱司韦®的上市许可申请获国家药品监督管理局正式受理并纳入优先审评审批程序
08 déc. 2022 20h00 HE
|
Shanghai Ark Biopharmaceutical Co., Ltd.
中国上海, Dec. 09, 2022 (GLOBE NEWSWIRE) -- 上海爱科百发生物医药技术股份有限公司（以下简称“ 爱科百发”），一家致力于儿科及呼吸疾病领域创新药研发的生物制药企业，今日宣布中国国家药品监督管理局正式受理治疗呼吸道合胞病毒（RSV）感染新药爱司韦®（通用名：齐瑞索韦/ziresovir）的上市许可申请（NDA），并且纳入“优先审评审批”程序。 ...
愛科百發宣佈呼吸道合胞病毒新藥愛司韋®的上市許可申請獲國家藥品監督管理局正式受理並納入優先審評審批程式
08 déc. 2022 20h00 HE
|
Shanghai Ark Biopharmaceutical Co., Ltd.
中國上海, Dec. 09, 2022 (GLOBE NEWSWIRE) -- 上海愛科百發生物醫藥技術股份有限公司（以下簡稱“ 愛科百發”），一家致力於兒科及呼吸疾病領域創新藥研發的生物製藥企業，今日宣佈中國國家藥品監督管理局正式受理治療呼吸道合胞病毒（RSV）感染新藥愛司韋®（通用名：齊瑞索韋/ziresovir）的上市許可申請（NDA），並且納入“優先審評審批”程式。 ...
Ark Biopharmaceutical Announces NMPA Acceptance and Priority Review of New Drug Application for Ziresovir for Treatment of RSV Infection
08 déc. 2022 20h00 HE
|
Shanghai Ark Biopharmaceutical Co., Ltd.
SHANGHAI, China, Dec. 08, 2022 (GLOBE NEWSWIRE) -- Shanghai Ark Biopharmaceutical Co., Ltd. (Ark Biopharmaceutical), a biopharma company dedicated to the discovery and development of drugs for...
Emergency Physicians: Avoid These ‘Health Scares’ on Halloween
28 oct. 2022 09h22 HE
|
American College of Emergency Physicians
WASHINGTON, D.C., Oct. 28, 2022 (GLOBE NEWSWIRE) -- Halloween is just around the corner, and the American College of Emergency Physicians (ACEP) urges all who celebrate to do so with their health...
NeuroSigma Announces Commercial Launch of The Monarch eTNS® System for the Treatment of Pediatric ADHD at Annual Meeting of the American Academy of Child and Adolescent Psychiatry
17 oct. 2022 09h00 HE
|
NeuroSigma, Inc.
LOS ANGELES, Oct. 17, 2022 (GLOBE NEWSWIRE) -- NeuroSigma, Inc., a Los Angeles-based bioelectronics company, today announced the commercial launch of The Monarch eTNS System at the annual meeting of...
爱科百发在第12届国际呼吸道合胞病毒（RSV）年会上报告了爱司韦™在RSV感染的住院婴幼儿中的三期临床试验（AIRFLO）积极结果
06 oct. 2022 23h39 HE
|
Shanghai Ark Biopharmaceutical Co., Ltd.
中国上海, Oct. 07, 2022 (GLOBE NEWSWIRE) --...